ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dihydroartemisinin Tablets Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-23I17608
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dihydroartemisinin Tablets Market Research Report 2024
BUY CHAPTERS

Global Dihydroartemisinin Tablets Market Research Report 2024

Code: QYRE-Auto-23I17608
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
KPC Pharmaceuticals
Guilin Nantang Pharmaceutical
Ipca Laboratories
Advacare Pharma
Centurion Healthcare
Schwitz Biotech

Dihydroartemisinin Tablets Market

Dihydroartemisinin tablets are a type of medication used primarily for the treatment of malaria. Dihydroartemisinin (DHA) is a potent antimalarial agent derived from artemisinin, a compound extracted from the sweet wormwood plant (Artemisia annua).
The global Dihydroartemisinin Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Dihydroartemisinin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dihydroartemisinin Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dihydroartemisinin Tablets include KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Ipca Laboratories, AdvaCare Pharma, Centurion Healthcare, Schwitz Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dihydroartemisinin Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dihydroartemisinin Tablets.
The Dihydroartemisinin Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Dihydroartemisinin Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dihydroartemisinin Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Dihydroartemisinin Tablets Market Report

Report Metric Details
Report Name Dihydroartemisinin Tablets Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Ipca Laboratories, AdvaCare Pharma, Centurion Healthcare, Schwitz Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dihydroartemisinin Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dihydroartemisinin Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Dihydroartemisinin Tablets Market report?

Ans: The main players in the Dihydroartemisinin Tablets Market are KPC Pharmaceuticals, Guilin Nantang Pharmaceutical, Ipca Laboratories, AdvaCare Pharma, Centurion Healthcare, Schwitz Biotech

What are the Application segmentation covered in the Dihydroartemisinin Tablets Market report?

Ans: The Applications covered in the Dihydroartemisinin Tablets Market report are Hospital Pharmacy, Retail Pharmacy

What are the Type segmentation covered in the Dihydroartemisinin Tablets Market report?

Ans: The Types covered in the Dihydroartemisinin Tablets Market report are Compound Dihydroartemisinin, Single Dihydroartemisinin

Recommended Reports

Tablet Pharmaceuticals

API & Drug Markets

Pharmaceutical Equipment

1 Dihydroartemisinin Tablets Market Overview
1.1 Product Definition
1.2 Dihydroartemisinin Tablets by Type
1.2.1 Global Dihydroartemisinin Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Compound Dihydroartemisinin
1.2.3 Single Dihydroartemisinin
1.3 Dihydroartemisinin Tablets by Application
1.3.1 Global Dihydroartemisinin Tablets Market Value by Application (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Global Dihydroartemisinin Tablets Market Size Estimates and Forecasts
1.4.1 Global Dihydroartemisinin Tablets Revenue 2019-2030
1.4.2 Global Dihydroartemisinin Tablets Sales 2019-2030
1.4.3 Global Dihydroartemisinin Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dihydroartemisinin Tablets Market Competition by Manufacturers
2.1 Global Dihydroartemisinin Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dihydroartemisinin Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dihydroartemisinin Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Dihydroartemisinin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dihydroartemisinin Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dihydroartemisinin Tablets, Product Type & Application
2.7 Global Key Manufacturers of Dihydroartemisinin Tablets, Date of Enter into This Industry
2.8 Global Dihydroartemisinin Tablets Market Competitive Situation and Trends
2.8.1 Global Dihydroartemisinin Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Dihydroartemisinin Tablets Players Market Share by Revenue
2.8.3 Global Dihydroartemisinin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Dihydroartemisinin Tablets Market Scenario by Region
3.1 Global Dihydroartemisinin Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dihydroartemisinin Tablets Sales by Region: 2019-2030
3.2.1 Global Dihydroartemisinin Tablets Sales by Region: 2019-2024
3.2.2 Global Dihydroartemisinin Tablets Sales by Region: 2025-2030
3.3 Global Dihydroartemisinin Tablets Revenue by Region: 2019-2030
3.3.1 Global Dihydroartemisinin Tablets Revenue by Region: 2019-2024
3.3.2 Global Dihydroartemisinin Tablets Revenue by Region: 2025-2030
3.4 North America Dihydroartemisinin Tablets Market Facts & Figures by Country
3.4.1 North America Dihydroartemisinin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dihydroartemisinin Tablets Sales by Country (2019-2030)
3.4.3 North America Dihydroartemisinin Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Dihydroartemisinin Tablets Market Facts & Figures by Country
3.5.1 Europe Dihydroartemisinin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dihydroartemisinin Tablets Sales by Country (2019-2030)
3.5.3 Europe Dihydroartemisinin Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dihydroartemisinin Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Dihydroartemisinin Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dihydroartemisinin Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Dihydroartemisinin Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Dihydroartemisinin Tablets Market Facts & Figures by Country
3.7.1 Latin America Dihydroartemisinin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dihydroartemisinin Tablets Sales by Country (2019-2030)
3.7.3 Latin America Dihydroartemisinin Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Dihydroartemisinin Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Dihydroartemisinin Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dihydroartemisinin Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dihydroartemisinin Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dihydroartemisinin Tablets Sales by Type (2019-2030)
4.1.1 Global Dihydroartemisinin Tablets Sales by Type (2019-2024)
4.1.2 Global Dihydroartemisinin Tablets Sales by Type (2025-2030)
4.1.3 Global Dihydroartemisinin Tablets Sales Market Share by Type (2019-2030)
4.2 Global Dihydroartemisinin Tablets Revenue by Type (2019-2030)
4.2.1 Global Dihydroartemisinin Tablets Revenue by Type (2019-2024)
4.2.2 Global Dihydroartemisinin Tablets Revenue by Type (2025-2030)
4.2.3 Global Dihydroartemisinin Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Dihydroartemisinin Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dihydroartemisinin Tablets Sales by Application (2019-2030)
5.1.1 Global Dihydroartemisinin Tablets Sales by Application (2019-2024)
5.1.2 Global Dihydroartemisinin Tablets Sales by Application (2025-2030)
5.1.3 Global Dihydroartemisinin Tablets Sales Market Share by Application (2019-2030)
5.2 Global Dihydroartemisinin Tablets Revenue by Application (2019-2030)
5.2.1 Global Dihydroartemisinin Tablets Revenue by Application (2019-2024)
5.2.2 Global Dihydroartemisinin Tablets Revenue by Application (2025-2030)
5.2.3 Global Dihydroartemisinin Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Dihydroartemisinin Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 KPC Pharmaceuticals
6.1.1 KPC Pharmaceuticals Company Information
6.1.2 KPC Pharmaceuticals Description and Business Overview
6.1.3 KPC Pharmaceuticals Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 KPC Pharmaceuticals Dihydroartemisinin Tablets Product Portfolio
6.1.5 KPC Pharmaceuticals Recent Developments/Updates
6.2 Guilin Nantang Pharmaceutical
6.2.1 Guilin Nantang Pharmaceutical Company Information
6.2.2 Guilin Nantang Pharmaceutical Description and Business Overview
6.2.3 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product Portfolio
6.2.5 Guilin Nantang Pharmaceutical Recent Developments/Updates
6.3 Ipca Laboratories
6.3.1 Ipca Laboratories Company Information
6.3.2 Ipca Laboratories Description and Business Overview
6.3.3 Ipca Laboratories Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ipca Laboratories Dihydroartemisinin Tablets Product Portfolio
6.3.5 Ipca Laboratories Recent Developments/Updates
6.4 AdvaCare Pharma
6.4.1 AdvaCare Pharma Company Information
6.4.2 AdvaCare Pharma Description and Business Overview
6.4.3 AdvaCare Pharma Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AdvaCare Pharma Dihydroartemisinin Tablets Product Portfolio
6.4.5 AdvaCare Pharma Recent Developments/Updates
6.5 Centurion Healthcare
6.5.1 Centurion Healthcare Company Information
6.5.2 Centurion Healthcare Description and Business Overview
6.5.3 Centurion Healthcare Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Centurion Healthcare Dihydroartemisinin Tablets Product Portfolio
6.5.5 Centurion Healthcare Recent Developments/Updates
6.6 Schwitz Biotech
6.6.1 Schwitz Biotech Company Information
6.6.2 Schwitz Biotech Description and Business Overview
6.6.3 Schwitz Biotech Dihydroartemisinin Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Schwitz Biotech Dihydroartemisinin Tablets Product Portfolio
6.6.5 Schwitz Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dihydroartemisinin Tablets Industry Chain Analysis
7.2 Dihydroartemisinin Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dihydroartemisinin Tablets Production Mode & Process
7.4 Dihydroartemisinin Tablets Sales and Marketing
7.4.1 Dihydroartemisinin Tablets Sales Channels
7.4.2 Dihydroartemisinin Tablets Distributors
7.5 Dihydroartemisinin Tablets Customers
8 Dihydroartemisinin Tablets Market Dynamics
8.1 Dihydroartemisinin Tablets Industry Trends
8.2 Dihydroartemisinin Tablets Market Drivers
8.3 Dihydroartemisinin Tablets Market Challenges
8.4 Dihydroartemisinin Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
KPC Pharmaceuticals
Guilin Nantang Pharmaceutical
Ipca Laboratories
Advacare Pharma
Centurion Healthcare
Schwitz Biotech
List of Tables
 Table 1. Global Dihydroartemisinin Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Dihydroartemisinin Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Dihydroartemisinin Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Dihydroartemisinin Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Dihydroartemisinin Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Dihydroartemisinin Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Dihydroartemisinin Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Dihydroartemisinin Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Dihydroartemisinin Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Dihydroartemisinin Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Dihydroartemisinin Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Dihydroartemisinin Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Dihydroartemisinin Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dihydroartemisinin Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dihydroartemisinin Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Dihydroartemisinin Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Dihydroartemisinin Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Dihydroartemisinin Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Dihydroartemisinin Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Dihydroartemisinin Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Dihydroartemisinin Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Dihydroartemisinin Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Dihydroartemisinin Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Dihydroartemisinin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Dihydroartemisinin Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Dihydroartemisinin Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Dihydroartemisinin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Dihydroartemisinin Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Dihydroartemisinin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Dihydroartemisinin Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Dihydroartemisinin Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Dihydroartemisinin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Dihydroartemisinin Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Dihydroartemisinin Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Dihydroartemisinin Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Dihydroartemisinin Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Dihydroartemisinin Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Dihydroartemisinin Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Dihydroartemisinin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Dihydroartemisinin Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Dihydroartemisinin Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Dihydroartemisinin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Dihydroartemisinin Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Dihydroartemisinin Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Dihydroartemisinin Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Dihydroartemisinin Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Dihydroartemisinin Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Dihydroartemisinin Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Dihydroartemisinin Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Dihydroartemisinin Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Dihydroartemisinin Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Dihydroartemisinin Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Dihydroartemisinin Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Dihydroartemisinin Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Dihydroartemisinin Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Dihydroartemisinin Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Dihydroartemisinin Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Dihydroartemisinin Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Dihydroartemisinin Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Dihydroartemisinin Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Dihydroartemisinin Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Dihydroartemisinin Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Dihydroartemisinin Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Dihydroartemisinin Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Dihydroartemisinin Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Dihydroartemisinin Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Dihydroartemisinin Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Dihydroartemisinin Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. KPC Pharmaceuticals Company Information
 Table 71. KPC Pharmaceuticals Description and Business Overview
 Table 72. KPC Pharmaceuticals Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. KPC Pharmaceuticals Dihydroartemisinin Tablets Product
 Table 74. KPC Pharmaceuticals Recent Developments/Updates
 Table 75. Guilin Nantang Pharmaceutical Company Information
 Table 76. Guilin Nantang Pharmaceutical Description and Business Overview
 Table 77. Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Guilin Nantang Pharmaceutical Dihydroartemisinin Tablets Product
 Table 79. Guilin Nantang Pharmaceutical Recent Developments/Updates
 Table 80. Ipca Laboratories Company Information
 Table 81. Ipca Laboratories Description and Business Overview
 Table 82. Ipca Laboratories Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Ipca Laboratories Dihydroartemisinin Tablets Product
 Table 84. Ipca Laboratories Recent Developments/Updates
 Table 85. AdvaCare Pharma Company Information
 Table 86. AdvaCare Pharma Description and Business Overview
 Table 87. AdvaCare Pharma Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. AdvaCare Pharma Dihydroartemisinin Tablets Product
 Table 89. AdvaCare Pharma Recent Developments/Updates
 Table 90. Centurion Healthcare Company Information
 Table 91. Centurion Healthcare Description and Business Overview
 Table 92. Centurion Healthcare Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Centurion Healthcare Dihydroartemisinin Tablets Product
 Table 94. Centurion Healthcare Recent Developments/Updates
 Table 95. Schwitz Biotech Company Information
 Table 96. Schwitz Biotech Description and Business Overview
 Table 97. Schwitz Biotech Dihydroartemisinin Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Schwitz Biotech Dihydroartemisinin Tablets Product
 Table 99. Schwitz Biotech Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Dihydroartemisinin Tablets Distributors List
 Table 103. Dihydroartemisinin Tablets Customers List
 Table 104. Dihydroartemisinin Tablets Market Trends
 Table 105. Dihydroartemisinin Tablets Market Drivers
 Table 106. Dihydroartemisinin Tablets Market Challenges
 Table 107. Dihydroartemisinin Tablets Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dihydroartemisinin Tablets
 Figure 2. Global Dihydroartemisinin Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Dihydroartemisinin Tablets Market Share by Type: 2023 & 2030
 Figure 4. Compound Dihydroartemisinin Product Picture
 Figure 5. Single Dihydroartemisinin Product Picture
 Figure 6. Global Dihydroartemisinin Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Dihydroartemisinin Tablets Market Share by Application: 2023 & 2030
 Figure 8. Hospital Pharmacy
 Figure 9. Retail Pharmacy
 Figure 10. Global Dihydroartemisinin Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 11. Global Dihydroartemisinin Tablets Market Size (2019-2030) & (US$ Million)
 Figure 12. Global Dihydroartemisinin Tablets Sales (2019-2030) & (K Units)
 Figure 13. Global Dihydroartemisinin Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 14. Dihydroartemisinin Tablets Report Years Considered
 Figure 15. Dihydroartemisinin Tablets Sales Share by Manufacturers in 2023
 Figure 16. Global Dihydroartemisinin Tablets Revenue Share by Manufacturers in 2023
 Figure 17. Global 5 and 10 Largest Dihydroartemisinin Tablets Players: Market Share by Revenue in Dihydroartemisinin Tablets in 2023
 Figure 18. Dihydroartemisinin Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. Global Dihydroartemisinin Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 20. North America Dihydroartemisinin Tablets Sales Market Share by Country (2019-2030)
 Figure 21. North America Dihydroartemisinin Tablets Revenue Market Share by Country (2019-2030)
 Figure 22. United States Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 23. Canada Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Europe Dihydroartemisinin Tablets Sales Market Share by Country (2019-2030)
 Figure 25. Europe Dihydroartemisinin Tablets Revenue Market Share by Country (2019-2030)
 Figure 26. Germany Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. France Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. U.K. Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. Italy Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Russia Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Asia Pacific Dihydroartemisinin Tablets Sales Market Share by Region (2019-2030)
 Figure 32. Asia Pacific Dihydroartemisinin Tablets Revenue Market Share by Region (2019-2030)
 Figure 33. China Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Japan Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. South Korea Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. India Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Australia Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. China Taiwan Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Southeast Asia Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Latin America Dihydroartemisinin Tablets Sales Market Share by Country (2019-2030)
 Figure 41. Mexico Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Brazil Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Argentina Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Colombia Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Middle East and Africa Dihydroartemisinin Tablets Sales Market Share by Country (2019-2030)
 Figure 46. Middle East and Africa Dihydroartemisinin Tablets Revenue Market Share by Country (2019-2030)
 Figure 47. Turkey Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Saudi Arabia Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. UAE Dihydroartemisinin Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Global Sales Market Share of Dihydroartemisinin Tablets by Type (2019-2030)
 Figure 51. Global Revenue Market Share of Dihydroartemisinin Tablets by Type (2019-2030)
 Figure 52. Global Dihydroartemisinin Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 53. Global Sales Market Share of Dihydroartemisinin Tablets by Application (2019-2030)
 Figure 54. Global Revenue Market Share of Dihydroartemisinin Tablets by Application (2019-2030)
 Figure 55. Global Dihydroartemisinin Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 56. Dihydroartemisinin Tablets Value Chain
 Figure 57. Dihydroartemisinin Tablets Production Process
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Dihydroartemisinin Market Research Report 2025
Global Artemisinin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Artesunate Tablet Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Oral Artemether Drugs Market Research Report 2024
Global Artemisinin Combination Therapy Market Insights Forecast to 2030
Global Artemether Lumefantrine Tablets Market Research Report 2024
Global Artesunate Market Research Report 2024
Global Dihydroxyacetone DHA Market Research Report 2024
Global DHA Powder for Dietary Supplements Market Insights Forecast to 2030
Global Compound Artemether Tablets Market Research Report 2024
Artesunate Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artemisinin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artemisinine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artesunate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global DHA Oil Powder Market Research Report 2024
Global Pyrimethamine Tablets Market Research Report 2025
Artesunate Used for Malaria Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Quinine Dihydrochloride Injection Market Research Report 2025
Global DHA Powder Market Insights Forecast to 2030
Global Marine Plant DHA Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions